Literature DB >> 30629044

Exercise Training Prevents Doxorubicin-induced Mitochondrial Dysfunction of the Liver.

J Matthew Hinkley1, Aaron B Morton1, Noriko Ichinoseki-Sekine1,2, Andres Mor Huertas1, Ashley J Smuder3.   

Abstract

PURPOSE: Doxorubicin (DOX) is a highly effective chemotherapeutic agent used in the treatment of a broad spectrum of cancers. However, clinical use of DOX is limited by irreversible and dose-dependent hepatotoxicity. The liver is the primary organ responsible for the clearance of antineoplastic agents, and evidence indicates that hepatotoxicity occurs as a result of impaired mitochondrial efficiency during DOX metabolism. In this regard, exercise training is sufficient to improve mitochondrial function and protect against DOX-induced cytotoxicity. Therefore, the purpose of this study was to determine whether short-term exercise preconditioning is sufficient to protect against DOX-induced liver mitochondrionopathy.
METHODS: Female Sprague-Dawley rats (4-6 months old) were randomly assigned to one of four groups: 1) sedentary, treated with saline; 2) sedentary, treated with DOX; 3) exercise trained, treated with saline; and 4) exercise trained, treated with DOX. Exercise-trained animals underwent 5 d of treadmill running habituation followed by 10 d of running for 60 min·d (30 m·min; 0% grade). After the last training bout, exercise-trained and sedentary animals were injected with either DOX (20 mg·kg i.p.) or saline. Two days after drug treatment, the liver was removed and mitochondria were isolated.
RESULTS: DOX treatment induced mitochondrial dysfunction of the liver in sedentary animals because of alterations in mitochondrial oxidative capacity, biogenesis, degradation, and protein acetylation. Furthermore, exercise preconditioning protected against DOX-mediated liver mitochondrionopathy, which was associated with the maintenance of mitochondrial oxidative capacity and protein acetylation.
CONCLUSION: These findings demonstrate that endurance exercise training protects against DOX-induced liver mitochondrial dysfunction, which was attributed to modifications in organelle oxidative capacity and mitochondrial protein acetylation.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30629044      PMCID: PMC6522307          DOI: 10.1249/MSS.0000000000001887

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  40 in total

1.  Increased mitochondrial emission of reactive oxygen species and calpain activation are required for doxorubicin-induced cardiac and skeletal muscle myopathy.

Authors:  Kisuk Min; Oh-Sung Kwon; Ashley J Smuder; Michael P Wiggs; Kurt J Sollanek; Demetra D Christou; Jeung-Ki Yoo; Moon-Hyon Hwang; Hazel H Szeto; Andreas N Kavazis; Scott K Powers
Journal:  J Physiol       Date:  2015-02-23       Impact factor: 5.182

2.  Targeted overexpression of mitochondrial catalase protects against cancer chemotherapy-induced skeletal muscle dysfunction.

Authors:  Laura A A Gilliam; Daniel S Lark; Lauren R Reese; Maria J Torres; Terence E Ryan; Chien-Te Lin; Brook L Cathey; P Darrell Neufer
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-06-21       Impact factor: 4.310

Review 3.  Mitochondrial protein acetylation regulates metabolism.

Authors:  Kristin A Anderson; Matthew D Hirschey
Journal:  Essays Biochem       Date:  2012       Impact factor: 8.000

4.  Sirt3 protects mitochondrial DNA damage and blocks the development of doxorubicin-induced cardiomyopathy in mice.

Authors:  Vinodkumar B Pillai; Samik Bindu; Will Sharp; Yong Hu Fang; Gene Kim; Madhu Gupta; Sadhana Samant; Mahesh P Gupta
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-02-12       Impact factor: 4.733

Review 5.  Structure of the adriamycin-cardiolipin complex. Role in mitochondrial toxicity.

Authors:  E Goormaghtigh; P Huart; M Praet; R Brasseur; J M Ruysschaert
Journal:  Biophys Chem       Date:  1990-04       Impact factor: 2.352

6.  Exercise protects against doxorubicin-induced markers of autophagy signaling in skeletal muscle.

Authors:  Ashley J Smuder; Andreas N Kavazis; Kisuk Min; Scott K Powers
Journal:  J Appl Physiol (1985)       Date:  2011-07-21

7.  Doxorubicin-induced oxidative stress in rats is efficiently counteracted by dietary anthocyanin differently enriched strawberry (Fragaria × ananassa Duch.).

Authors:  Jacopo Diamanti; Bruno Mezzetti; Francesca Giampieri; José M Alvarez-Suarez; José L Quiles; Adrian Gonzalez-Alonso; Maria del Carmen Ramirez-Tortosa; Sergio Granados-Principal; Ana M Gonzáles-Paramás; Celestino Santos-Buelga; Maurizio Battino
Journal:  J Agric Food Chem       Date:  2014-03-11       Impact factor: 5.279

8.  Age-related effect of aerobic exercise training on antioxidant and oxidative markers in the liver challenged by doxorubicin in rats.

Authors:  Mehdi Ahmadian; Valiollah Dabidi Roshan; Anthony S Leicht
Journal:  Free Radic Res       Date:  2018-05-16

9.  Impact of various exercise modalities on hepatic mitochondrial function.

Authors:  Justin A Fletcher; Grace M Meers; Melissa A Linden; Monica L Kearney; E Matthew Morris; John P Thyfault; R Scott Rector
Journal:  Med Sci Sports Exerc       Date:  2014-06       Impact factor: 5.411

Review 10.  The mitochondrial kinase PINK1: functions beyond mitophagy.

Authors:  Aaron Voigt; Lena A Berlemann; Konstanze F Winklhofer
Journal:  J Neurochem       Date:  2016-06-02       Impact factor: 5.372

View more
  3 in total

1.  Exercise stimulates beneficial adaptations to diminish doxorubicin-induced cellular toxicity.

Authors:  Ashley J Smuder
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-08-28       Impact factor: 3.619

Review 2.  Physical Exercise and Selective Autophagy: Benefit and Risk on Cardiovascular Health.

Authors:  Ne N Wu; Haili Tian; Peijie Chen; Dan Wang; Jun Ren; Yingmei Zhang
Journal:  Cells       Date:  2019-11-14       Impact factor: 6.600

3.  Exercise training restores IGFIR survival signaling in d-galactose induced-aging rats to suppress cardiac apoptosis.

Authors:  Ing-Shiow Lay; Wei-Wen Kuo; Marthandam Asokan Shibu; Tsung-Jung Ho; Shiu-Min Cheng; Cecilia Hsuan Day; Bo Ban; Shulin Wang; Qiaowen Li; Chih-Yang Huang
Journal:  J Adv Res       Date:  2020-06-20       Impact factor: 10.479

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.